![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/30 | |
C07K 14/42 | |||
A61K 47/68 |
(11) | Number of the document | 3102244 |
(13) | Kind of document | T |
(96) | European patent application number | 15705778.7 |
Date of filing the European patent application | 2015-02-04 | |
(97) | Date of publication of the European application | 2016-12-14 |
(45) | Date of publication and mention of the grant of the patent | 2020-03-18 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2015/052341 |
Date | 2015-02-04 |
(87) | Number | WO 2015/118030 |
Date | 2015-08-13 |
(30) | Number | Date | Country code |
201402006 | 2014-02-06 | GB |
(72) |
KONTERMANN, Roland, ES
PFIZENMAIER, Klaus, ES
FERRER, Cristina, ES
FABRE, Myriam, ES
SIMON, Laureano, ES
|
(73) |
Oncomatryx Biopharma, S.L.,
Parque Tecnol gico de Bizkaia Edificio 801-B 2° planta, 48160 Derio (Vizcaya),
ES
|
(54) | ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS |
ANTIBODY-DRUG CONJUGATES AND IMMUNOTOXINS |